Coeptis appoints Colleen Delaney as chief scientific and medical officer

Colleen Delaney, who has more than two decades of experience as an oncologist and stem cell transplant physician-scientist, also has served on numerous cell and gene therapy-focused federal advisory committees and as a director at several nonprofit associations.